Mycophenolate Mofetil Market

Mycophenolate mofetil, also known as MMF or CellCept, is a prodrug of mycophenolic acid, and classified as a reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH).?This drug is an immunosuppressant combined with drugs such as?Cyclosporine?and corticosteroids to prevent organ rejection after hepatic, renal, and cardiac transplants.

Mycophenolate Mofetil Market contains market size and forecasts of Mycophenolate Mofetil (MMF) in Global, including the following market information:

Global Mycophenolate Mofetil (MMF) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Mycophenolate Mofetil (MMF) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Mycophenolate Mofetil (MMF) include Roche, Genentech, Teva, Sandoz (Novartis), West Ward Pharmaceuticals, Accord Healthcare, Mylan, Strides Pharma and Jubilant Cadista, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Mycophenolate Mofetil (MMF) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Mycophenolate Mofetil (MMF) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Mycophenolate Mofetil (MMF) Market Segment Percentages, by Type, 2021 (%)

Tablets

Capsule

Topical Suspension

Injection

Other

Global Mycophenolate Mofetil (MMF) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mycophenolate Mofetil (MMF) Market Segment Percentages, by Application, 2021 (%)

Pemphigus

Bullous Pemphigoid

Systemic Lupus Erythematosus (SLE)

Psoriasis

Other

Global Mycophenolate Mofetil (MMF) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mycophenolate Mofetil (MMF) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mycophenolate Mofetil (MMF) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Mycophenolate Mofetil (MMF) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Genentech

Teva

Sandoz (Novartis)

West Ward Pharmaceuticals

Accord Healthcare

Mylan

Strides Pharma

Jubilant Cadista

Alkem Laboratories

Akorn

Passauer Pharma GmbH

Par Pharmaceutical (Endo International)

Sinopharm Group

Shuanghe Pharmaceutical

Shandong Xinshidai

Wuxi Hequan Pharmaceutical

Kunming Fengkenuo Pharmaceutical

Zhejiang Zhongfeng Pharmaceutical

Hubei Ji Antang Pharmaceutical

Hunan Huanda Pharmaceutical

Hubei Huanda Pharmaceutical

Hubei Pharmaceutical

Wuxi Fuxi Pharmaceutical

Huadong Pharmaceutical

Zhejiang Jianfeng Pharmaceutical

Zhejiang Haizheng Pharmaceutical